From: Diffusion tensor magnetic resonance imaging in differentiation of breast lesions
Benign | Malignant | T test | ||
---|---|---|---|---|
(n = 26) | (n = 24) | P-value | ||
Clinical data | Age (years) | 39.23 ± 10.70 | 57.25 ± 12.48 | < 0.001* |
Parity Nulliparous (%) | 35 | 65 | < 0.001* | |
Family history Positive (%) | 38 | 62 | < 0.001* |
(n = 23) | (n = 22) | χ2 Test | ||
---|---|---|---|---|
P-value | ||||
Enhancement pattern | Homogenous enhancing mass | 13 (56.52%) | 4 (18.18%) | < 0.01* |
Non mass enhancement | 5 (21.74%) | 9 (40.91%) | ||
Heterogeneous enhancing mass | 3 (13.04%) | 9 (40.91%) | ||
Focus enhancement | 1 (4.35%) | 0 | ||
Mass with ring enhancement | 1 (4.35%) | 0 | ||
Total | 23 (100%) | 22 (100%) | 100 | |
Kinetic curve | Type I | 20 (86.95%) | 1 (4.6%) | < 0.001* |
Types 2 and 3 | 3 (13.05%) | 21 (95.4%) | ||
Sens | Spec | PPV | NPV | Accuracy |
95.4% | 86.95% | 95.4 | 86.95 | 91.1% |
Kinetic curve | T-test | |||
---|---|---|---|---|
Type I | Type II and III | t | P-value | |
ADC (×10−3 mm2/s) | 1.375 ± 0.124 | 1.068 ± 0.259 | 5.105 | < 0.001* |